Emma Walmsley
The Reformer
Changing the system from inside it, principle turned into change.
Emma Walmsley is The Reformer by demonstration. Arriving at GSK as an outsider to pharmaceuticals, she set about redesigning the company from within, separating consumer health into Haleon, sharpening pipeline discipline, and overhauling R&D decision-making without dismantling the institution around her. That pairing of operational rigour with structural reinvention, progressive yet grounded, is the Reformer signature. She modernised a legacy giant not by tearing it down but by redrawing its architecture.
“The world will pay a very big price, not just for COVID but beyond that, if we break trust in the quality of vaccination. It has frankly been the biggest contribution to human health since clean water.”
“Right from the beginning we said at GSK our principles were around global access. We would not expect to profit from any COVID vaccine during the pandemic phase; we would reinvest any short term profits in pandemic preparedness.”
“The first principle should be the people who get it first are the people who need it most.”
The David Rubenstein Show: “Emma Walmsley”
LISTEN AT THE SOURCE ↗THE RECORD IS CHECKABLE